Olvera Nuria, Agusti Alvar, Vonk Judith M, Wang Gang, Hallberg Jenny, Boezen H Marike, van den Berge Maarten, Melén Erik, Faner Rosa
Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBER), Barcelona, Spain.
Respirology. 2025 Apr;30(4):326-334. doi: 10.1111/resp.14876. Epub 2025 Jan 12.
Some individuals never achieve normal peak FEV in early adulthood. It is unknown if this is due to airflow limitation and/or lung restriction.
To investigate this, we: (1) looked forward in 19,791 participants in the Dutch Lifelines general population cohort aged 25-35 years with 5-year follow-up; and (2) looked backwards in 2032 participants in the Swedish BAMSE birth cohort with spirometry at 24 years of age but also at 16 and/or 8 years.
(1) In Lifelines 8.5% of participants had reduced FEV at 25-35 years, 68% due to Preserved Ratio Impaired Spirometry ('PRISm') and 32% to airflow limitation ('low-limited'); besides, 3.8% participants with normal FEV showed airflow-limitation ('normal-limited'). Low-limited and normal-limited, but not PRISm, reported higher smoking exposures and asthma diagnosis than normal (p < 0.05). At 5-year follow-up, 91.2% of participants remained in the same group, and FEV decline was similar in normal and normal-limited participants, but statistically smaller (p < 0.05) in PRISm and low-limited; (2) these observations were largely reproduced in BAMSE at 24 years of age; and, (3) in BAMSE, low-limited or PRISm individuals were already identifiable at 8-16 years of age.
Low peak FEV in early adulthood is most often due to PRISm and results in a significant burden of respiratory symptoms. Only low-limited and normal-limited, but not PRISm, associate with a doctor diagnosis of asthma, and FEV decline was statistically different in PRISm indicating a need for differentiated clinical approaches. These spirometric abnormalities can be already identified in childhood and adolescence.
一些人在成年早期从未达到正常的FEV峰值。目前尚不清楚这是由于气流受限和/或肺限制。
为了对此进行调查,我们:(1)前瞻性观察了荷兰生命线一般人群队列中19791名年龄在25 - 35岁的参与者,并进行了5年随访;(2)回顾性观察了瑞典BAMSE出生队列中2032名参与者,他们在24岁时进行了肺活量测定,同时在16岁和/或8岁时也进行了测定。
(1)在生命线队列中,8.5%的参与者在25 - 35岁时FEV降低,68%归因于肺量计测量值保留比例受损(“PRISm”),32%归因于气流受限(“低受限”);此外,3.8%的FEV正常的参与者表现出气流受限(“正常受限”)。低受限和正常受限(而非PRISm)的参与者报告的吸烟暴露和哮喘诊断率高于正常参与者(p < 0.05)。在5年随访中,91.2%的参与者仍处于同一组,正常和正常受限参与者的FEV下降相似,但PRISm和低受限参与者的FEV下降在统计学上较小(p < 0.05);(2)这些观察结果在24岁的BAMSE队列中基本重现;(3)在BAMSE队列中,低受限或PRISm个体在8 - 16岁时就已可识别。
成年早期FEV峰值低最常见的原因是PRISm,并导致明显的呼吸道症状负担。只有低受限和正常受限(而非PRISm)与医生诊断的哮喘相关,且PRISm患者的FEV下降在统计学上有所不同,这表明需要采用差异化的临床方法。这些肺量计异常在儿童和青少年时期就已可识别。